NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY

NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY is a manufacturer.

Company Introduction:

NANOGEN PHARMACEUTICAL BIOTECHNOLOGY JOINT STOCK COMPANY is a leading Vietnamese biopharmaceutical enterprise dedicated to the research, development, and manufacturing of advanced biological products, vaccines, and pharmaceutical drugs. The company is renowned for its strong focus on biotechnology and its significant contributions to public health and medical innovation within Vietnam and internationally.

Nanogen operates modern, state-of-the-art research and production facilities that adhere to stringent international quality standards, including Good Manufacturing Practices (GMP). Its core activities span various biopharmaceutical areas, from the discovery of novel therapeutic agents to the production of high-quality, accessible medicines. The company is committed to leveraging scientific advancements to address unmet medical needs and enhance the quality of life for patients. Nanogen has played a crucial role in developing and producing critical biological products, demonstrating its capability in complex pharmaceutical manufacturing.

Nanogen Pharmaceutical Biotechnology Joint Stock Company manufactures or sells the following products:

Recombinant proteins

Biosimilar drugs

Vaccines including Hepatitis B vaccine and COVID-19 vaccine candidates

Growth factors such as Filgrastim and Erythropoietin

Interferons including Interferon alpha 2a and Interferon alpha 2b

Insulin and other drugs for metabolic disorders

Oncology drugs including Rituximab, Trastuzumab, Bevacizumab, and Cetuximab

Drugs for autoimmune diseases including Infliximab, Etanercept, and Adalimumab

Hematology drugs

Diagnostic kits